CTEC.L
CTEC.L
GB00BD3VFW73
CONVATEC GROUP PLC ORD 10P
Loading chart...

Company Profile

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Related stocks

STVN
STVN • Italy
Stevanato Group S.p.A.
19.4 USD
5.3B USD 1Y -21.8%
YPSN.SW
YPSN.SW • Switzerland
YPSOMED HLDG
362.2 CHF
5.74B USD 1Y +6.9%
OBCK.DE
OBCK.DE • Germany
Ottobock SE & Co. KGaA I
53.2 EUR
3.81B USD
1SXP.DE
1SXP.DE • Germany
SCHOTT Pharma AG & Co. KGaA I
23.5 EUR
3.97B USD 1Y +20%
FIE.DE
FIE.DE • Germany
Fielmann Group AG I
37.35 EUR
3.51B USD 1Y -25.6%
TECN.SW
TECN.SW • Switzerland
TECAN GROUP AG N
235 CHF
3.49B USD 1Y +55.4%
AMS.L
AMS.L • United Kingdom
ADVANCED MEDICAL SOLUTIONS GROU
282 GBp
812.43M USD 1Y +24.4%
SKAN.SW
SKAN.SW • Switzerland
SKAN N
70.7 CHF
1.92B USD 1Y +22.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.1% p.a.
Max Drawdown (5Y)
-34.3%
Sharpe Ratio (5Y)
-0.06
Beta Factor
0.77
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -65.5% in the extended horizon.
ende